|
|
| Maladies Digestives > Etude de marché sectorielle |
| UK Digestive Remedies 2004 |
|
|
|
|
€ 240,00 |
Editeur
: |
Snapshots International |
Langue
: |
Anglais |
Date de publication : |
Juillet 2004 |
Taille du document : |
14 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Key Trends in Nutraceutical Food and Drinks: Novel ingredients, new applications and future revenue opportunities
254 pages | Janvier 2007 |
As the global population ages, fast foods become more prevalent and distrust of traditional pharmaceuticals grows, the pressure on the food and drinks industry to provide cost effective solutions for |
1 528,00 €
|
| |
| |
OTC Digestive Remedies in France
10 pages | Juin 2005 |
Euromonitor International’s ‘OTC Digestive Remedies in France' Major Market Profile report offers an introduction to the market.
It is c.
10 pages long and provides a top line overview of sales |
198,00 €
|
| |
| |
OTC Digestive Remedies in France
10 pages | Juin 2004 |
· OTC Digestive Remedies: Market SizeThe French market for digestive remedies declined by 1% on the previous year, reaching €295 million (US$333 million) in 2003.
· OTC D |
198,00 €
|
| |
| |
OTC Digestive Remedies in the UK
15 pages | Juillet 2002 |
The UK market for OTC digestive remedies has grown by 1.4% since 2000 to reach a value of £133.1 million (US$192.5 million) in 2001.
The market for digestive remedies increased significantly in val |
198,00 €
|
| |
| |
US Gastrointestinal Remedies 2004
12 pages | Novembre 2004 |
Snapdata's US Gastrointestinal Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US gastrointestinal |
240,00 €
|
| |
| |
US State Market Index: Endocrine products
12 pages | Juillet 2006 |
The metrics in this report cover three year trends in Endocrine products [Manufacturing sector], broken out on a state-by-state basis.
Analysis is based on data applied from 1 industry firms.
In |
475,00 €
|
| |
| |
Commercial Insight: Antidyslipidemics - Cholesterol Absorption of Lipitor's Dominance
76 pages | Juin 2005 |
IntroductionThe next 10 years will see six statins lose patent protection, with the potential loss of over $20 billion across the seven major markets.
However, their established position as first-l |
12 160,00 €
|
| |
| |
US State Market Index: Drugs affecting neoplasms and endrocrine systems
12 pages | Juillet 2006 |
The metrics in this report cover three year trends in Drugs affecting neoplasms and endrocrine systems [Manufacturing sector], broken out on a state-by-state basis.
Analysis is based on data applie |
475,00 €
|
| |
| |
US State Market Index: Laxatives
12 pages | Juillet 2006 |
The metrics in this report cover three year trends in Laxatives [Manufacturing sector], broken out on a state-by-state basis.
Analysis is based on data applied from 3 industry firms.
Industry ma |
475,00 €
|
| |
| |
Decubitus Ulcer Treatment Products
281 pages | Octobre 2005 |
This report analyzes the worldwide markets for Decubitus Ulcer Treatment Products in Millions of US$.
The specific product segments analyzed are Air Fluidized Bed, Low Air Loss Beds, Air Wave Mattr |
2 308,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| UK Digestive Remedies 2004 |
|
|
Snapdata's UK Digestive Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the UK digestive remedy market, and covers non-prescription treatments for indigestion, constipation, diarrhoea (diarrhea), stomach upsets, travel sickness and irritable bowel syndrome (IBS). The data is supplied in both graphical and tabular format for ease of interpretation and analysis. UK Digestive Remedies 2004 forms part of Snapdata's OTC Pharmaceuticals industry coverage.
|
|
Page 3 - Executive Summary
Page 4 - Category Definitions
Page 5 - Market Size by Value (1999-2003)
Page 6 - Market Segmentation by Value
Page 7 - Market Ranking by Value (Indigestion)
Page 8 - Market Ranking by Value (Laxatives)
Page 9 - Market Ranking by Value (Diarrhoea)
Page 10 - Company Details (Main Players)
Page 11 - Distribution Channels by Value
Page 12 - Market Forecast by Value (2004-2008)
Page 13 - Socio-Economic Data for UK
Page 14 - Sources for Further Research
UK,healthcare,otc,over-the-counter,pharmaceuticals,antacids,Indigestion,Laxatives,Diarrhoea,Stomach upsets,Travel sickness,Irritable bowel syndrome,IBS,GlaxoSmithKline,Gaviscon,Roche,Rennie,Pfizer,Zantac 75,Johnson & Johnson,Pepcid,Bisodol,Indigestion Remedies,Senokot,Dulcolax,Fybogel,Ex-lax,Califig,Imodium,Dioral,Arzneimittel (nicht verschreibungspflichtig),Automédication,Vereinigtes Königreich,Royaume Unis,Verdauungsmittel,Remèdes digestifs
|
|
|
PPLSEN
|
|
|
|
|
